These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12088930)

  • 1. Nateglinide, but not repaglinide, stimulates growth hormone release in rat pituitary cells by inhibition of K channels and stimulation of cyclic AMP-dependent exocytosis.
    Gromada J; Bokvist K; Høy M; Olsen HL; Lindström P; Hansen BS; Gotfredsen CF; Rorsman P; Thomsen MK
    Eur J Endocrinol; 2002 Jul; 147(1):133-42. PubMed ID: 12088930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.
    Bokvist K; Hoy M; Buschard K; Holst JJ; Thomsen MK; Gromada J
    Eur J Pharmacol; 1999 Dec; 386(1):105-11. PubMed ID: 10611470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulinotropic agent nateglinide on Kv and Ca(2+) channels in pancreatic beta-cell.
    Hu S; Wang S
    Eur J Pharmacol; 2001 Sep; 427(2):97-104. PubMed ID: 11557260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action.
    Hu S
    Eur J Pharmacol; 2002 May; 442(1-2):163-71. PubMed ID: 12020694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide at a cellular level.
    Krogsgaard Thomsen M; Bokvist K; Høy M; Buschard K; Holst JJ; Lindström P; Gromada J
    Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):15-8. PubMed ID: 12702003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.
    Hu S; Wang S; Dunning BE
    Int J Exp Diabetes Res; 2001; 2(1):63-72. PubMed ID: 12369728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
    Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
    Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.
    Hansen AM; Christensen IT; Hansen JB; Carr RD; Ashcroft FM; Wahl P
    Diabetes; 2002 Sep; 51(9):2789-95. PubMed ID: 12196472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.
    Hu S; Wang S; Dunning BE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1372-9. PubMed ID: 10565863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of I k in the anti-apoptotic action of PACAP.
    Mei YA; Vaudry D; Basille M; Castel H; Fournier A; Vaudry H; Gonzalez BJ
    Eur J Neurosci; 2004 Mar; 19(6):1446-58. PubMed ID: 15066141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.
    Malaisse WJ
    Treat Endocrinol; 2003; 2(6):401-14. PubMed ID: 15981944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.
    Høy M; Olsen HL; Andersen HS; Bokvist K; Buschard K; Hansen J; Jacobsen P; Petersen JS; Rorsman P; Gromada J
    Eur J Pharmacol; 2003 Apr; 466(1-2):213-21. PubMed ID: 12679159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse intracellular signalling systems used by growth hormone-releasing hormone in regulating voltage-gated Ca2+ or K channels in pituitary somatotropes.
    Chen C; Xu R; Clarke IJ; Ruan M; Loneragan K; Roh SG
    Immunol Cell Biol; 2000 Aug; 78(4):356-68. PubMed ID: 10947860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.
    McClenaghan NH; Flatt PR; Ball AJ
    J Endocrinol; 2006 Sep; 190(3):889-96. PubMed ID: 17003289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic protein kinase A mediates the growth hormone (GH)-releasing action of GH-releasing factor in purified rat somatotrophs.
    Wong AO; Moor BC; Hawkins CE; Narayanan N; Kraicer J
    Neuroendocrinology; 1995 May; 61(5):590-600. PubMed ID: 7617138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations.
    Malaisse WJ
    Pharmacol Res; 1995 Sep; 32(3):111-4. PubMed ID: 8745339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolbutamide stimulates exocytosis of glucagon by inhibition of a mitochondrial-like ATP-sensitive K+ (KATP) conductance in rat pancreatic A-cells.
    Høy M; Olsen HL; Bokvist K; Buschard K; Barg S; Rorsman P; Gromada J
    J Physiol; 2000 Aug; 527 Pt 1(Pt 1):109-20. PubMed ID: 10944174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.
    Kalbag JB; Walter YH; Nedelman JR; McLeod JF
    Diabetes Care; 2001 Jan; 24(1):73-7. PubMed ID: 11194245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells.
    Akiyoshi M; Kakei M; Nakazaki M; Tanaka H
    Am J Physiol; 1995 Feb; 268(2 Pt 1):E185-93. PubMed ID: 7864093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.